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ARF6 adenosine diphosphate-ribosylation factor 6 
Cdc42 cell division cycle protein 42 
CLSM confocal laser scanning microscopy 
CPP cell-penetrating peptide 
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GTP guanosine triphosphate 
HSPG heparan sulfate proteoglycan 
LAMP-2 lysosome-associated membrane protein 2 
MAP model amphipathic peptide 
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pVEC cell-penetrating peptide derived from vascular endothelial 
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TGN trans-Golgi network 
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Many potential therapeutic molecules or other biologically active compounds 
that are efficient in solutions are not able to traverse eukaryotic cell membranes 
and, therefore, can not be utilized in living cells. To confer the barrier function 
of the plasma membrane, different delivery methods have been developed. 
However, many of these have at least some limitations, for example, they are 
generally invasive and/or can not be applied in living organisms.  
Discovery of sequences derived from full proteins that display cell-pene-
trating properties, however, has helped to pave the way for the development of 
efficient peptidic transport vectors. These so called cell-penetrating peptides 
(CPPs, also known as protein transduction domains or membrane translocating 
sequences) are able to efficiently gain access into cells and, furthermore, 
transport various payloads attached to them into intracellular compartments in a 
non-invasive manner. To date, CPPs have been used to deliver different types of 
molecules with a wide range of size, such as small interfering RNA and peptide 
nucleic acid oligomers as well as full length proteins and plasmids or even 
nanoparticles and liposomes. Moreover, their potential as efficient delivery 
vehicles has repeatedly been demonstrated both in vitro and in vivo.  
Before these promising transport vectors can be used in therapeutic bio-
medicine, their mechanism of entry needs to be carefully elucidated. At present, 
there is no unambiguous agreement on the uptake pathways exploited by CPPs, 
because characteristics of the peptide, its concentration, and cargo molecule 
may all play a role in the selection of uptake pathway. Nevertheless, it appears 
that several well-known CPPs are able to interact with membrane lipids and 
induce disturbances in the plasma membrane before they are taken up by cells. 
This, in turn, may be harmful for cells, and it is not known how cells can cope 
with the potential stress caused by the uptake of CPPs. 
Therefore, the main focus of this study was to elucidate the membrane 
destabilizing capacity of several CPPs belonging to different families, including 
protein-derived, chimeric, and artificial ones. Since disturbances in the lipid 
bilayer might hinder the barrier function of the plasma membrane, we assessed 
whether CPPs are able induce the influx of calcium ions into cells. Furthermore, 
activation of different downstream responses that would help cells to reseal the 
damaged cell surface regions and deal with the detrimental influx of calcium 
were studied. In addition, we characterized the interaction of relatively novel 
S413-PV peptides with the cell surface, their uptake pathways, and intracellular 
localization in order to reveal the determinants responsible for their different 
membrane disturbing effects and uptake efficiency.  
The knowledge obtained from the present study might help to improve the 
understanding of processes involved in the uptake of CPPs and, therefore, gives 
valuable information for the ongoing development of CPPs as transport vectors. 
Furthermore, it helps to recognize that not all seemingly harmful side-effects 




1. LITERATURE OVERVIEW 
1.1. Plasma membrane barrier 
Plasma membrane is a dynamic and complex structure that defines the bounda-
ries of eukaryotic cells. It is mainly composed of various lipids (e.g. phos-
pholipids, glycolipids, cholesterol) that self-assemble into a bilayer because of 
their amphipathic nature and hydrophobic interactions. The polar head-groups 
of lipids interact with water, while the hydrophobic tails favor contact with one 
another, forming a double-layer sheet-like structure with a hydrophobic core 
that acts as a permeability barrier. This barrier prevents essential cytoplasmic 
components from leaking out and, at the same time, protects cells from harmful 
molecules from diffusing in. In addition to lipids, specific proteins are embed-
ded into the bilayer that mediate distinctive functions of the plasma membrane. 
Selective permeability of the membrane, for example, is facilitated by proteins 
that act as pumps or channels for small uncharged polar molecules or ions. Yet, 
these transport systems are not able to assist the internalization of larger hydro-
philic compounds. 
In biomedicine and scientific research, however, insertion or delivery of 
potential bioactive molecules into cells, in order to modulate cellular processes 
and functions, has become of high importance. Since these compounds are 
generally not taken up by cellular transport systems, numerous methods have 
been developed to bypass this obstacle. Direct microinjection into cells, electro-
poration, utilization of virus-based delivery vectors, or cationic lipids (lipo-
plexes), to name a few, are all relevant approaches to transport various 
compounds into mammalian cells. At the same time, application of these 
methods has lead to the discovery of their various drawbacks and side-effects. 
For example, many of these methods can be employed only in in vitro systems, 
and their usage in cellular tissues or organisms is rather complicated or not fea-
sible at all. In addition, other aspects (such as the stability of the carrier systems 
in blood stream, low or heterogeneous yield, and acute toxicity) have to be care-
fully considered before their application in vivo. However, the discovery of 
relatively short amino acid sequences with cell-penetrating properties in mid-
1990s has become a considerable alternative to the methods mentioned above.  
 
 
1.2. Cell-penetrating peptides 
CPPs represent a large family of peptides that are efficiently taken up by eu-
karyotic cells and are able to transport numerous cargo molecules into intra-
cellular environment. Because of this remarkable property, they have gained 
much attention as transport vehicles for biologically active compounds that per 
se are cell impermeable and, therefore, would not be suitable for therapeutic 
purposes. However, attachment of these payloads to CPPs makes them ulti-
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mately functional for biomedical approaches and research. Moreover, appli-
cation of CPPs has less side-effects and drawbacks as compared to the other 
“classical” methods used to facilitate the uptake of cell-impermeable molecules. 
Namely, CPPs are homogeneously taken up by all cell types studied so far, they 
exhibit less cytotoxicity and no immunogenicity and, more importantly, CPPs 
can be used in vivo. 
After the discovery of first CPPs, the researchers have put much effort into 
this field to find more efficient transport peptides with fewer side-effects (e.g. 
lower cytotoxicity or greater resistance to degradation) and/or demonstrating 
specific targeting ability to certain tissues or organs. As a result, already over a 
hundred peptides possessing cell-penetrating properties have been identified at 
present. CPPs are usually short, 5–40 amino acid long sequences that often con-
tain basic amino acids in their sequence. However, many of them display dif-
ferent primary structures and chemical properties, making it rather complicated 
to divide CPPs into subgroups or families. One possibility is to divide them 
according to their origin to:  
a) protein-derived CPPs, such as Tat-peptide (Vivés et al., 1997), penetratin 
(Derossi et al., 1994), and pVEC (Elmquist et al., 2001); 
b) chimeric CPPs, such as transportans (Pooga et al., 1998; Soomets et al., 2000) 
and S413-PV (Hariton-Gazal et al., 2002);  
c) entirely synthetic or designed CPPs, such as model amphipathic peptide 
(MAP) (Oehlke et al., 1998) and oligoarginines (Futaki et al., 2001; Mitchell 
et al., 2000). 
 
However, this classification does not give any clues about their chemical or 
physical properties, interaction with the plasma membrane, internalization effi-
ciency, or toxicity. Therefore, quite recently, André Ziegler (Ziegler, 2008) 
proposed a new classification system for CPPs that is based on the peptide 
sequence and different peptide-lipid binding affinities. According to this, CPPs 




1.2.1. Primary amphipathic peptides 
Like the name implies, primary amphipathic CPPs consist of cationic and 
hydrophobic segments that reside sequentially in the primary structure of the 
peptide. Their interaction with the membrane lipids is governed by hydrophobic 
interactions rather than electrostatic ones, since they are able to bind with both 
anionic and neutral lipid membranes with a high affinity (Ziegler, 2008). In 
general, primary amphipathic CPPs penetrate deeper into the lipid bilayer 
(Deshayes et al., 2004); however, they do not span the membrane in a pore like 
manner unless a transmembrane potential is present (Deshayes et al., 2006). 
CPPs that can be categorized under this group are, for example, transportans. 
Transportan (TP) is a 27 amino acid long chimeric peptide. It consists of a seg-
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ment of neuropeptide galanin (first 13 amino acids of TP) and a segment of the 
wasp venom mastoparan that are linked via a lysine-residue (Pooga et al., 1998). 
The lysine linker was incorporated to enable attachment of different reporter 
groups (e.g. biotin and fluorophores) to the peptide. Even though TP is effi-
ciently taken up by cells via receptor-independent pathway, it also exhibits an 
inhibitory effect on the basal GTPase activity (Zorko et al., 1998) that might 
become an obstacle in the utilization of TP as a carrier peptide. Therefore, 
several deletion analogues of transportan were designed to find a peptide with-
out the above-mentioned side-effect but with similar translocation efficiency 
(Soomets et al., 2000). This resulted in the discovery of TP10, a truncated 
version of TP that lacks six amino acids from the N-terminus. Nevertheless, it 
shows comparable uptake levels with TP with lower cytotoxic effects. In the 
presence of membrane lipids, the mastoparan part of transportan adopts an  
α-helical conformation, while the galanin part stays more unstructured (Barany-
Wallje et al., 2004).  
The model amphipathic peptide (MAP, also known as KLAL) is a synthetic 
peptide that is composed of lysine, alanine, and leucine (Steiner et al., 1991). As 
a classical amphipathic peptide, it adopts an α-helical conformation where 
hydrophobic amino acids localize on one side and basic amino acids on the 
opposite side. Originally it was thought that amphipathic nature of MAP is 
crucial for the cellular uptake of the peptide (Oehlke et al., 1998); however, 
later studies revealed that non-amphipathic analogues are also taken up by cells 
(Scheller et al., 2000). It has been demonstrated that MAP is able to enter the 
cells both via energy-dependent and -independent mechanisms (Oehlke et al., 
1998; Oehlke et al., 2004). Although MAP rapidly internalizes into cells and 
efficiently delivers cargo molecules, it also exhibits profound toxicity; namely, 
MAP induces membrane leakage already at 1 µM concentration (Hällbrink et al., 
2001). Even though Ziegler has categorized MAP under secondary amphipathic 
peptides, we would rather place it under primary amphipathic ones. First, 
secondary amphipathic CPPs acquire their secondary structure upon binding to 
negatively charged membranes. However, MAP adopts its helical conformation 
already in the “membrane-mimicking” solvent, and the helical content is similar 
in the presence of both neutral and negatively charged lipids (Dathe et al., 1996). 
Secondly, the insertion of secondary amphipathic CPPs into the lipid bilayer is 
not pronounced. MAP peptide, however, inserts deeply into lipid layers, and 
most surprisingly, the membrane-disturbing effect of MAP significantly 
increases with reduction of the negative surface charge of the liposomes (Dathe 
et al., 1996; Erbe et al., 2009). And finally, primary amphipathic CPPs induce 
membrane leakage already at low micromolar concentration that is also con-





1.2.2. Secondary amphipathic peptides 
Secondary amphipathic CPPs expose their amphipathic nature after a change in 
their secondary structure upon binding to the membrane lipids or cell surface 
sugars. Therefore, when a peptide adopts either α-helical conformation or  
β-strand structure (Futaki et al., 2001; Lamaziere et al., 2007; Oehlke et al., 
1997), basic amino acids and hydrophobic amino acids are displayed on the 
opposite sides. Furthermore, these CPPs do not bind efficiently to neutral 
membrane lipids (Ghibaudi et al., 2005; Magzoub et al., 2001); however, the 
affinity increases by several orders of magnitude with the anionic lipid content 
of the membrane (Ziegler, 2008). As was mentioned above, secondary amphi-
pathic CPPs are not buried deep inside the lipid bilayer (Persson et al., 2004; 
Persson et al., 2003).  
By far the most studied secondary amphipathic CPP is penetratin. It is 16 
amino acid long CPP that corresponds to the third helix of the Drosophila 
Antennapedia homeodomain (Derossi et al., 1994). Basic amino acids are 
important for the efficient cellular uptake of penetratin, since the substitution of 
any of these residues with an uncharged alanin results in a decreased uptake of 
the peptide (Drin et al., 2001; Fischer et al., 2000). Hydrophobic amino acids 
are also essential, since the substitution of tryptophans with phenylalanines 
reduces the translocation efficiency drastically (Dom et al., 2003). It has  
been demonstrated that penetratin can adopt an α-helical conformation, or a  
β-structure, or stay unstructured. Thus, conformational changes in the secondary 
structure of penetratin highly depend on the concentration of the peptide and the 
membrane lipid composition (Bellet-Amalric et al., 2000; Derossi et al., 1994; 
Drin et al., 2001; Magzoub et al., 2002; Maniti et al., 2010). 
pVEC is a CPP derived from the cell adhesion molecule of murine vascular 
endothelial cadherin. It corresponds to the hydrophobic segment of 5 amino 
acids from the transmembrane region and a hydrophilic segment of 13 amino 
acids from the cytosolic tail of the protein. The amphipathic nature of pVEC has 
been suggested to be essential for the cellular uptake of the peptide (Elmquist et 
al., 2001).  
The S413-PV peptide is a chimeric CPP that contains a cell-penetrating 
sequence of 13 amino acids derived from Dermaseptin S4 peptide and the 
nuclear localization signal (NLS) of the Simian Virus 40 large T antigen 
(Hariton-Gazal et al., 2002). In addition to the wild-type S413-PV, analogues 
with reversed NLS and scrambled sequence are known. Upon binding to nega-
tively charged lipids, the wild-type S4 -PV and its analogue with reversed NLS 13
undergo significant conformational changes that are consistent with the for-
mation of helical structures. However, the conformational changes of the scram-





1.2.3. Non-amphipathic peptides 
Non-amphipathic CPPs contain a high number of cationic amino acids in their 
sequence and, consequently, do not exhibit any amphipathicity in their primary 
or secondary structure. These peptides do not bind to lipids (Magzoub et al., 
2001), but rather float on or are only superficially absorbed to the membranes 
(Goncalves et al., 2005; Ziegler et al., 2003; Tiriveedhi and Butko, 2007). In 
addition, non-amphipathic CPPs do not change their conformation in the 
presence of membrane lipids, and they do not penetrate into lipid monolayers at 
physiologically relevant surface pressures (Ziegler et al., 2003). As such, they 
are not able to translocate across lipid membranes at biologically relevant 
concentrations (1–10 µM) (Krämer and Wunderli-Allenspach, 2003; Lamaziere 
et al., 2007; Ziegler et al., 2003; Tiriveedhi and Butko, 2007). 
Highly cationic Tat-peptide is derived from Tat protein that is a human 
immunodeficiency virus (HIV) transcription factor (Vivés et al., 1997). After 
the discovery of translocation properties of the full-length protein (Frankel and 
Pabo, 1988; Green and Loewenstein, 1988), shorter sequences were synthesized 
to define the most efficiently internalizing peptide. This resulted in Tat(48–60) 
that is currently known as Tat-peptide (Vivés et al., 1997). Even though Tat-
peptide is one of the most studied non-amphipathic CPPs, the mechanism(s) by 
which it is taken up into cells is still a great puzzle. It appears that Tat-peptide is 
able to exploit all possible internalization pathways available, including 
clathrin-dependent endocytosis (Richard et al., 2005; Richard et al., 2003), 
caveolin-dependent endocytosis (Ferrari et al., 2003; Fittipaldi et al., 2003), and 
macropinocytosis (Al Soraj et al., 2012; Wadia et al., 2004), in addition to 
receptor- and energy-independent mechanisms (Futaki et al., 2001; Ziegler et al., 
2005). 
Since highly cationic CPPs (penetratin and Tat-peptide) were amongst the 
first CPPs discovered, basic amino acids were considered to be essential for the 
cellular uptake. Therefore, several homopolymers composed of arginine, lysine, 
ornithine, or histidine were synthesized and their translocation abilities were 
compared (Futaki et al., 2001; Mitchell et al., 2000; Wender et al., 2000). 
Amongst the studied polymers, polyarginines demonstrated the highest inter-
nalization efficiency that can be attributed to the guanidinium group of the argi-
nine side-chain, since it can form multidentate hydrogen bonds with the phos-
phates of lipid head-groups and facilitate the adaptive translocation of the pep-
tide (Rothbard et al., 2005). However, the length of oligoarginines plays a role 
also in their internalization capacity. Namely, oligomers composed of less than 
six arginines are poor translocators, 6–9 arginines are most efficiently taken up 
by cells, and the longer analogues already exhibit cytotoxic side-effects 
(Mitchell et al., 2000). 
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1.3. Internalization mechanisms  
of cell-penetrating peptides 
The uptake pathways by which CPPs or their constructs with cargo molecules 
gain access into cells are by far more complex than was originally thought. A 
number of recent studies have demonstrated the change between different cellu-
lar distribution patterns of CPPs in response to the shift of experimental con-
ditions, like the concentration of CPP, temperature, and the size of cargo. 
Therefore, currently, a growing number of studies support the view that CPPs 
enter cells by using different mechanisms that act in parallel, and for most CPPs 
probably more than one uptake pathway exists.  
  
 
1.3.1. Crossing the plasma membrane 
After the discovery of CPPs, the prevailing route of internalization of these 
peptides was considered to be a receptor- and energy-independent penetration 
across the membrane bilayer. However, around a decade later it was discovered 
that fixation of cells may lead to the redistribution of CPPs and, therefore, re-
evaluation of the uptake mechanisms was enforced (Richard et al., 2003). This, 
in turn, has led to the generally accepted belief that CPPs mostly exploit 
different types of endocytic pathways to enter cells. Nevertheless, it has been 
demonstrated by several groups that under certain conditions at least a fraction 
of CPPs is able to enter cells via direct translocation. For instance, the uptake 
mechanisms of non-amphipathic CPPs has been reported to change from 
endocytic pathway to direct translocation upon raising the concentration of the 
peptide or by lowering the incubation temperature (Fretz et al., 2007; Watkins 
et al., 2009). A change to non-endocytic uptake pathway at higher peptide con-
centrations has also been confirmed for secondary amphipathic S413-PV (Mano 
et al., 2005). However, the direct translocation of CPPs might become ham-
pered by the addition of a larger cargo molecule; namely, Tünnemann and 
collegues (Tünnemann et al., 2006) demonstrated that attachment of a cargo 
molecule (>50 amino acids) to Tat-peptide changed the internalization mecha-
nism of the peptide from a direct translocation to an endocytic uptake.  
The ability of CPPs to translocate across lipid bilayers is also supported by 
several biophysical studies demonstrating that some CPPs interact with lipids 
and, as a result, are embedded deeper into the membrane. For example, MAP 
peptide that adopts an α-helical conformation, interacts not only with the lipid 
head-groups, but also with the hydrophobic core of the membranes. Namely, 
MAP is able to intercalate between the lipid side-chains under a 60° degree 
angle (Erbe et al., 2009). In addition, wild-type S413-PV and its analogue with 
reversed NLS are partially able to adopt an α-helical conformation and insert 
deeper into the lipid bilayer that is considered to be essential for the non-
endocytic uptake of these CPPs (Mano et al., 2007; Mano et al., 2006). 
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1.3.2. Endocytosis 
Endocytosis is classically divided into phagocytosis and pinocytosis. The 
first one is typical for specialized cells and is mainly used for the uptake of 
pathogens, dead cells, and cell debris. The second one, however, is distinctive to 
almost all eukaryotic cells, and can be further divided into several pathways 
depending on the proteins and lipids involved in the vesicle formation stadium.  
Figure 1. Acknowledged pinocytotic pathways and intracellular trafficking of 
endocytosed material in mammalian cells. GEEC – glycosylphosphatidylinositol-
anchored protein enriched early endosomal compartment, MVB – multivesicular body, 
TGN – trans-Golgi network. 
Endocytosis is a process by which eukaryotic cells take up macromolecules and 
fluids from the surrounding environment by forming relatively small 
membrane-enclosed sacs termed endocytic vesicles that pinch off from the 
plasma membrane and are subsequently targeted to specific sub-cellular 
destinations. Besides being a fundamental pathway for the uptake of nutrients, it 
also plays a central role in the regulation of cell surface receptors, controls 
several signaling cascades, and is important for cell division and motility 
(Doherty and McMahon, 2009; Hoeller et al., 2005). In addition, some bacteria 
and viruses are able to take advantage of this route of uptake to gain access into 
cells (Dimitrov, 2004; Gruenberg and van der Goot, 2006; Mercer et al., 2010; 
Steele-Mortimer et al., 2000).  
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1.3.2.1. Clathrin-mediated endocytosis 
Clathrin-mediated endocytosis is by far the most studied receptor-dependent 
endocytosis that is initiated by the binding of a ligand to the trans-membrane 
receptor molecule on the cell surface. This association process triggers the for-
mation of coated pits on the cytosolic side of the plasma membrane. The “coat” 
is assembled by recruitment of different proteins, where clathrin is the main unit. 
Clathrin is a protein that has a three-legged structure (triskelion) composed of 
three clathrin heavy chains and three light chains (Heuser and Keen, 1988; 
Smith et al., 1998). When these triskelions assemble, they form a curved lattice 
under the plasma membrane that eventually drives the invagination of anchored 
membrane and the formation of clathrin-coated pits. Even though clathrin is 
able to spontaneously assemble into “cages” in vitro (Ford et al., 2002), under 
physiological conditions this process is mediated by recruitment of specific 
adaptor and accessory proteins (Brodsky et al., 2001; Ehrlich et al., 2004; 
Schmid, 1997), because clathrin itself does not interact directly with the 
membrane. In addition, adaptor proteins (e.g. AP-2) serve as recognition sites 
for different sorting signals and cargoes (Traub, 2009).  
The final step in the vesicle formation process is its fission from the cell sur-
face. This process is mediated and regulated by a protein from GTPase family – 
dynamin – that assembles into an helical collar around the neck of the forming 
vesicle and irreversibly detaches it from the plasma membrane (Herzog et al., 
1977; Johnson, 1972). GTPase activity of dynamin is triggered by the inter-
action with phosphoinositides and phosphatidylinositol-4,5-bisphosphate 
(Barylko et al., 1998; Zheng et al., 1996; Tuma et al., 1993) and as a result vesi-
cles, usually with 100–150 nm in diameter, pinch off. Once the vesicle is 
detached, the clathrin-coat rapidly disassembles enabling the clathrin to recycle 
back to the plasma membrane while the vesicle is further trafficked to endocytic 
compartments.  
Several viral pathogens target the receptors of clathrin-mediated endocytosis 
and, therefore, are taken up by this pathway. Studies describing the uptake of 
pathogens, both viruses and bacteria, have also shed light on the flexibility in 
the regulation mechanisms of clathrin-coated vesicle formation. More precisely, 
virus particles more often induce the formation of clathrin-coated pits at the site 
of binding to the plasma membrane rather than entering via preassembled one 
(Marsh and Helenius, 2006). In addition, L. monocytogenes, a microorganism 
many times larger than a normal endocytic cargo, invades cells via clathrin-
mediated endocytosis (Veiga and Cossart, 2005). 
Since CPPs can interact with cell surface heparan sulfate proteoglycans 
(HSPG), it is believed that, as a consequence, they are internalized through 
clathrin-mediated endocytosis, because binding of ligands to surface sugars 
(such as HSPG) triggers their clustering and uptake by this type of endocytosis 
(Richard et al., 2005). In addition, several other studies have demonstrated that 
CPPs or CPPs with their payloads are able to exploit this pathway to enter the 
cells (Padari et al., 2005; Rinne et al., 2007; Vendeville et al., 2004).  
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1.3.2.2. Caveolin-mediated endocytosis 
Caveolins are 21 kDa transmembrane proteins that are anchored into the lipid 
bilayer from the cytosolic side by a hydrophobic sequence, and as a result form 
a hairpin loop with both amino- and carboxy-terminal regions facing the cyto-
plasm (Dupree et al., 1993; Pelkmans and Helenius, 2002). Caveolin-1 is re-
sponsible for the structural formation of caveolae (from Latin, little caves) 
(Pelkmans and Zerial, 2005) that are defined as 50–80 nm large flask shaped 
invaginations (Palade, 1953; Yamada, 1955). Therefore, caveolins are referred 
to as the membrane coat proteins for caveolae. Recently, it was found that a 
cytoplasmic protein called cavin-1, in parallel with caveolin-1, is required for 
the formation and function of caveolae (Hill et al., 2008; Liu and Pilch, 2008). 
Since caveolins reside in highly ordered lipid microdomains called lipid rafts 
(Tagawa et al., 2005), caveolae are also abundant in glycosphingolipids, lipid-
anchored proteins, and cholesterol.  
Caveolin-mediated endocytic pathway is involved in many biological pro-
cesses, such as lipid regulation, cell signaling, vesicular transport (Anderson, 
1998; Kurzchalia and Parton, 1999; Pelkmans and Helenius, 2002; Rothberg et 
al., 1992), and most prominently in transcytosis (Frank et al., 2009; Tuma and 
Hubbard, 2003). It has also been suggested that caveolae can act as membrane 
tension regulators (Raucher and Sheetz, 1999; Sens and Turner, 2006). Further-
more, several toxins and viruses (e.g. tetanus, cholera, Simian Virus 40) enter 
the cells via this pathway (Anderson et al., 1996; Herreros et al., 2001; 
Shogomori and Futerman, 2001; Stang et al., 1997).  
Despite the fact that caveolae are associated with several biological func-
tions, there is scarce information available about the specific receptors, and the 
mechanism by which cargo molecules are concentrated in caveloae is not under-
stood. However, it has been demonstrated that CPP-cargo constructs, such as 
protein complexes with Tat-peptide or transportans, are taken up by cells via 
caveolin-mediated endocytosis (Ferrari et al., 2003; Fittipaldi et al., 2003; 
Säälik et al., 2009), and that this route contributes up to 60–70% of uptake in 




Macropinocytosis is an actin driven endocytic pathway that was for many years 
thought to occur via non-selective membrane uptake (McNeil, 1984). However, 
macropinocytosis is now defined as a highly coordinated and dynamic process 
that involves membrane ruffling and subsequent engulfment of a large quantity 
of extracellular fluids by the formation of large uncoated vesicles (usually 
200 nm – 2 μm in size) called macropinosomes (Bar-Sagi and Feramisco, 1986; 
Dowrick et al., 1993; Swanson and Watts, 1995). Depending on the cell type 
and activation pathway, plasma membrane ruffling can lead to the formation of 
different types of membrane outgrowths. More precisely, lamellipodia-like 
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protrusions (Matin et al., 2002; Mercer and Helenius, 2009), circular cup-
shaped ruffles (Araki et al., 2000; Dowrick et al., 1993; Orth and McNiven, 
2006), and large plasma membrane extrusions called blebs (Mercer and 
Helenius, 2008; Mercer and Helenius, 2009) are all found to be able to induce 
micropinosomes once they “fall back” onto the cell surface. However, only a 
small fraction of these “collapsing” events lead to the formation of endocytic 
vesicles.  
The formation of membrane outgrowths can be stimulated with the acti-
vation of growth factor receptors (Dowrick et al., 1993; Hewlett et al., 1994; 
Kerr and Teasdale, 2009), apoptotic bodies, necrotic cells, and pathogens, such 
as bacteria and viruses (Ammendolia et al., 2004; Kerr and Teasdale, 2009; 
Mercer and Helenius, 2008; Mercer and Helenius, 2009). The process itself is 
driven by actin polymerization that is mediated by small family of Rho 
GTPases, such as Rac1 that is activated already in the early steps of macro-
pinocytosis (Ridley et al., 1992; Swanson, 2008). In addition to activation of 
Rac1 upon binding of epidermal growth factor to its receptor, generation of 
phosphoinositide 4,5-bisphosphate is initiated that, in turn, leads to the 
activation of several downstream proteins resulting in the modulation of actin 
polymerization (Kerr and Teasdale, 2009; Lee and Knecht, 2002; Mercer and 
Helenius, 2009; Wang et al., 2008; Vidricaire and Tremblay, 2007). 
Furthermore, CtBP1/BARS (C-termnal-binding protein-1/brefeldin A ribo-
sylation substrate) proteins localize to the region and affect macropinosome 
membrane closure in a phosphorylation-dependent manner (Liberali et al., 
2008). 
Like with the other endocytic pathways, once the pinocytotic vesicle is 
formed, it has to be detached from the plasma membrane. In case the micro-
pinocytosis occurs by lamellipodia-like and circular ruffles, the fission process 
is regulated by dynamin (Doherty and McMahon, 2008; Herzog et al., 1977). 
However, bleb-associated macropinocytosis is found to be dynamin inde-
pendent (Mercer and Helenius, 2008). 
Uptake of CPP-protein conjugates has been demonstrated to be sensitive to 
specific inhibitors and regulators of macropinocytosis (Al Soraj et al., 2012; 
Wadia et al., 2004), thus, implying the involvement of macropinocytosis in the 
internalization of these constructs. Furthermore, the ability of CPPs to activate 
Rac1, and the subsequent remodeling of actin cytoskeleton by CPPs or their 
constructs with cargo, has been confirmed repeatedly (Gerbal-Chaloin et al., 
2007; Imamura et al., 2011; Nakase et al., 2004).  
 
1.3.2.4. Other clathrin-independent carrier pathways 
Besides the classical endocytic pathways, the discovery of other uptake mecha-
nisms mediated by vesicular or tubular carriers has expanded drastically. For 
instance, currently, we can distinguish flotillin-, RhoA, Cdc42-, and ARF6-
mediated uptake pathways. Most probably, however, other clathrin- and 
caveolin-independent pathways also exist and are yet to be discovered.  
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Flotillins (also known as reggies) are structurally similar to caveolins. 
Namely, they are palmitoylated proteins that adopt a hairpin-like conformation 
in the lipid bilayer (Stuermer, 2010). In addition to structural similarities, 
flotillins are recognized as markers of lipid rafts because they reside in deter-
gent insoluble membrane fractions. Since caveolins are also confined into lipid 
rafts, it was found that flotillins localize into caveolae-like structures (Blanchet 
et al., 2008; Frick et al., 2007; Glebov et al., 2006; Morrow and Parton, 2005). 
However, flotillins associate with these structures only once they are formed 
(Kirkham et al., 2008) inducing the formation of membrane microdomains that 
subsequently internalize GPI-anchored proteins and fluid phase cargos (Frick et 
al., 2007; Glebov et al., 2006). 
Cdc42 (cell division cycle 42) is a protein that belongs to the Ras super-
family of GTP-binding proteins and, therefore, regulates actin cytoskeleton that 
is important for several cellular mechanisms, such as control of growth, 
differentiation, and apoptosis of cells. Cdc42-mediated endocytosis pathway is 
associated with the formation of tubular invaginations (30–50 nm wide and 
200–600 nm long) on the plasma membrane (Kirkham et al., 2005) that is 
initiated by the clustering of GPI-anchored proteins that interact with Cdc42 and 
are subsequently internalized (Mayor and Riezman, 2004). In addition, GTPase 
GRAF1 (GTPase regulator associated with focal adhesion kinase-1) was 
recently shown to also localize in tubular endocytic structures involved in the 
uptake of glycosphingolipids, GPI-linked proteins, etc (Doherty and Lundmark, 
2009; Lundmark et al., 2008). 
ARF6 (ADP-ribosylation factor 6) is a member of the ARF family of six 
small GTPases that are expressed in all eukaryotic cells (Donaldson, 2003). The 
role of ARF6 in clathrin-independent endocytosis is not fully understood yet, 
however, this pathway is morphologically associated with tubular rather than 
vesicular structures (Caplan et al., 2002; Massol et al., 2005). ARF6 is a protein 
that most likely regulates membrane curvature; more specifically, binding of 
ARF6 to GTP depends on membrane-curvature that, in turn, generates even 
more profound curvature. Because ARF6 has a BAR (Bin/Amphiphysin/Rsv) 
domain that is able to sense changes in membrane curvature (Frost et al., 2009; 
Masuda and Mochizuki, 2010; Qualmann et al., 2011; Suetsugu et al., 2010), 
the membrane budding is facilitated by the BAR domain that inserts into the 
lipid bilayer (Lundmark et al., 2008).  
RhoA also belongs to the Ras homolog gene family (Ridley, 1997), and its 
main function is to control actin cytoskeleton dynamics. To be exact, it regu-
lates gene expression, actin filament reorganization, determination of the cell 
shape, and proliferation (Hsu et al., 2003; Zhang and Zheng, 1998). First impli-
cations for RhoA-mediated endocytic uptake mechanisms came from the dis-
covery that the receptor for interleukin-2 is internalized via this pathway 
(Lamaze et al., 2001). Later it was demonstrated to control the uptake of ricin 
(Dalton et al., 2006) and Baculovirus (Grafahrend et al., 2008). However, it is 
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not known whether RhoA is required for the sorting of the receptors into the 
endocytic vesicles or during the whole endocytic process itself.  
The role of these pathways in the uptake of CPPs has not been thoroughly 
elucidated because of the lack of specific markers and inhibitors that would help 
to unambiguously identify clathrin- and caveolin-independent endocytosis. 
However, the ability of CPPs to trigger the remodeling of the actin cytoskeleton 
(Al Soraj et al., 2012; Nakase et al., 2004) might not be confined only to macro-
pinocytosis, since regulation of actin dynamics is also involved in Cdc42-, 
ARF6-, and RhoA-mediated endocytosis. 
 
 
1.3.2.5. Endocytic compartments 
After the formed vesicles pinch of from the cell surface, they are targeted into 
complex machinery of endocytic compartments that continuously sort and inter-
change their content by fusion with each other or by communicating via traf-
ficking vesicles. This process is spatiotemporally segregated and highly 
dynamic, generally resulting in receptor recycling and/or cargo degradation. 
The first sorting station is the early endosomal compartment that consists of 
large vesicles (300–400 nm diameter) and cisternae regions with slender tubules 
(60–80 nm diameter). Endocytic vesicles reach here within 1–5 min after they 
are pinched off from the plasma membrane. Early endosomes are rich in 
GTPase Rab5 and phoshatidylinositol-3-phosphate, and target their content (i) 
back to the plasma membrane either directly or via recycling endosomes, (ii) to 
trans-Golgi network (TGN), or (iii) to lysosomes for degradation (Haas et al., 
2005; Marshansky and Futai, 2008; Rybin et al., 1996).  
The multivesicular parts of early endosomes lead to the formation of 
multivesicular bodies (MVBs). Specifically, MVBs are believed to evolve from 
the early endosomal compartment by forming intraluminal vesicles from the 
limiting membrane of the compartment (Eden et al., 2009; Gruenberg and 
Stenmark, 2004; Hurley et al., 2010; van der Goot and Gruenberg, 2006) even-
tually leading to the formation of globular MVB that acidify their lumen to 
about pH 5.5.  
MVBs deliver their content to late endosomes that are structures also rich in 
tubules, intraluminal vesicles, and effector molecule Rab7 (Pfeffer, 2001). 
These regions have different protein and lipid composition to further assist the 
sorting of the internalized material (Gruenberg, 2003; Russell et al., 2006). 
Eventually, late endosomes deliver their content to lysosomes that are the final 
station of the endocytic pathway. The material designated for degradation 
reaches lysosomes in about 30 min from its entry into cells. Lysosomes are 
acidic organelles (pH 4.5–5.0) that contain a high number of soluble lysosomal 
hydrolases with each having a specific substrate (Saftig and Klumperman, 2009).  
The above discussed trafficking routes are conventional for all endocytic 
pathways. However, some exceptions have been described, especially in the 
early steps of trafficking. In case of caveolin-mediated endocytosis, the 
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caveolae first fuse with an organelle called the caveosome. This rosette-like 
structure is rich in caveolin-1, and has a lumen with neutral pH (Nichols, 2002; 
Pelkmans et al., 2001; Pietiainen et al., 2004). From there, the material is further 
targeted to the early endosomes, TGN, or endoplasmatic reticulum (Pelkmans et 
al., 2004). In case of flotillin-, Cdc42-, and ARF6-mediated endocytosis, the 
vesicles are first transported to a specific organelle termed the GPI-enriched 
early endosomal compartment (GEEC), where GPI-anchored proteins are 
recycled back to the plasma membrane (Sabharanjak et al., 2002). However, 
rest of the content may be directed to the early endosomes or to the Golgi 
network (Doherty and Lundmark, 2009). 
Membrane proteins that are confined into recycling endosomes are usually 
transported back to the plasma membrane (Mellman, 1996). The effector 
molecules that are associated with the recycling endosomes are Rab4 and Rab11 
(Pfeffer, 2001); however, Rab4-positive vesicles facilitate rather quick 
recycling events, whereas Rab11-containing endosomes localize into the 
perinuclear region and, therefore, contribute to a slower recycling pathway 
(Sheff et al., 1999).  
 
 
1.4. Membrane repair response 
Organisms are often exposed to all possible stimuli and, in some cases, to chal-
lenging surroundings that may lead to injuries and wounding. Even otherwise 
normal biological processes, such as muscle contraction (McNeil and Khakee, 
1992), can lead to disruption of the plasma membrane. Fortunately, all or-
ganisms studied so far – protists (Szubinska, 1971), yeast (Levin, 2005), bac-
teria (Hambleton, 1971), and multicellular organisms (Los et al., 2011) – are 
able to deal with these unexpected downsides to a certain extent by initiating 
healing processes. Proficient self-repair is apparent in all levels of biological 
organization including cells, tissues, organs, and organisms. In spite of the level, 
wound healing process addresses several aspects during the repair: the injury 
site is patched up, redundant material is degraded or expelled, the material lost 
as a result of wounding is regenerated, and finally, all of the evidence of the 
damage is removed. 
Characterization and analysis of single-cell wound repair response did not 
gain much research interest until relatively recently (McNeil and Steinhardt, 
2003). McNeil with colleagues showed that the plasma membrane repair is a an 
universal response in different mammalian cell types and that resealing of the 
wound is an active cellular process rather than a passive reorganization of mem-
brane lipids as it was generally believed (McNeil et al., 2003).  
The membrane repair response (MRR) is initiated by the influx of calcium 
ions into cells. Under normal conditions, the cytosolic Ca2+ concentration is 
maintained low (micromolar range) by the bidirectional ion transport across the 
plasma membrane, however, extracellular Ca2+ concentrations are much higher 
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(millimolar range). Therefore, in case of injury, the barrier function of the 
plasma membrane is breached and the cell interior is exposed to the high exter-
nal Ca2+ levels that can be harmful, or even toxic to the cells. Influx of Ca2+ 
triggers rapid fusion of intracellular vesicles with each other forming a large 
membranous “patch” that can be used to seal the disruption site (McNeil et al., 
2000). This prevents the cell from being killed as a result of either continuous 
influx of Ca2+, or the efflux of essential cytoplasmic components.  
Originally, it was proposed that lysosomes are the major, if not the only, 
membranous organelles that can be used for resealing the plasma membrane 
(Jaiswal et al., 2002; Reddy et al., 2001). However, it is reasonable to assume 
that most of the membranous compartments near the injury site could be 
exploited (Bement et al., 2007; Borgonovo et al., 2002; Mellgren, 2010; Shen et 
al., 2005). Though, the exact mechanisms by which the fusion events are 
governed are poorly defined so far. This process probably involves SNAREs 
(soluble N-ethylmaleimide-sensitive factor attachment protein receptor) 
(Steinhardt et al., 1994) and synaptotagmin (Shen et al., 2005), since it is sensi-
tive to toxins that target these proteins. In addition, annexins (McNeil et al., 
2006) and other proteins (Bansal et al., 2003; Cai et al., 2009) are potential 
regulators of membrane fusion events. 
The MRR is assisted by a transient, local disassembly of the cortical actin 
network beneath the injury site that most probably facilitates local exocytosis 
(Godin et al., 2011; Miyake et al., 2001). However, the mechanisms by which 
the local actin disassembly is controlled, is not well characterized yet.  
In addition, the replacement of lipids originating from the intracellular 
compartments with the intrinsic plasma membrane ones is not fully understood, 
however, it might involve microtubule-dependent membrane trafficking. Even 
though wounding initially triggers local, calcium-dependent depolymerization 
of microtubules, the microtubules polymerize and are transported back to the 
disruption site within ~1 min of wounding. As a result, the site of injury is 
surrounded by a radial array of microtubules (Mandato and Bement, 2003; Togo, 
2006). Thereafter, the Golgi apparatus-derived vesicles are transported along 
the microtubules to the wound region (Togo, 2006), and as these are thought to 
be responsible for replenishing the plasma membrane lipids and proteins during 
constitutive exocytosis (Jaiswal et al., 2009), this might also be the case during 
the plasma membrane repair. 
After the damaged region of the cell surface is patched up, the integrity of 
the actin cytoskeleton beneath it needs to be restored. This is probably facili-
tated by the accumulation of F-actin and myosin-2 to the wound region (Bement 
et al., 1999; Godin et al., 2011; Mandato and Bement, 2001; Miyake et al., 
2001). The assembly F-actin and myosin-2 into a purse string around the injury 
is directed by RhoA and Cdc42. Specifically, active RhoA directs myosin-2 
accumulation right at the edge of the wound, whereas Cdc42 directs dynamic 
actin assembly several micrometers further, leading to the formation of 
concentric rings around the wound (Benink and Bement, 2005; Vaughan et al., 
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2011). The closure of a purse string (Bement and Capco, 1991; Bement et al., 
1999) pulls unwounded plasma membrane inward, facilitating membrane repair. 
As a final step, the patching membrane must be removed to restore the initial 
state of the plasma membrane. The elimination might be accomplished by either 
endocytosis or expulsion of the plasma membrane extensions. It has been 
demonstrated that besides local exocytosis, injury triggers also local endo-
cytosis (Bi et al., 1995; Idone et al., 2008; Keefe et al., 2005). In addition, 
wounding can trigger extensive formation of blebs and thin tubular extensions 
(Babiychuk et al., 2009; Babiychuk et al., 2011; Geuskens and Tencer, 1979; 
Morgan et al., 1987). However, this is highly hypothetical, since the activation 
of endocytosis was demonstrated in the studies with pore-forming proteins (e.g 
cytolytic perforin and bacterial toxin streptolysin), and this process might con-
tribute to the removal of transmembrane pores that must be eliminated from the 
cell surface for cells to survive. Furthermore, the formation of plasma 
membrane blebs at the injury sites might be a particular defense mechanism as 
well. Namely, a bleb acts as a trap that blocks the excessive influx of Ca2+, since 
the bleb “neck” is plugged by calcium-sensitive proteins until the damaged 
plasma membrane regions are repaired (Babiychuk et al., 2011). 
  
 
Figure 2. Membrane repair response in single cells. Membrane damage allows the 
influx of calcium ions down its concentration gradient into the cell activating 
depolymerization of the cortical actin cytoskeleton. At the same time intracellular 
vesicles rush to the site of injury and fuse with each other to form a “patch” that is used 
to plug the wound region, followed by the restoration of cortical actin cytoskeleton. 
PM – plasma membrane.  
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2. AIMS OF THE STUDY 
Cell-penetrating peptides have gained much attention because of their high 
efficiency to deliver otherwise impermeable cargo molecules into cellular 
tissues. Even though it is recognized that the uptake mode might change after 
the addition of a cargo molecule to the CPP, it is of high importance to 
understand the behavior of the peptides in cellular environment that will 
contribute to our current understanding of how CPPs cross biological 
membranes and enter cells. Therefore, to tackle the complex puzzle of CPP-
membrane interactions, potential membrane destabilization, and downstream 
responses, we have mostly focused on the internalization pathways of CPPs 
alone. 
 
More specifically our goals were: 
 to characterize novel sequences derived from perforin, granulysin, and 
granzyme B proteins and compare their cell-penetrating properties with 
MAP and penetratin. In addition, to investigate whether the internalization 
of the CPPs into cells induces disturbances in the plasma membrane suffi-
cient enough to cause the influx of calcium, triggers the exocytosis of lyso-
somes, and activates membrane repair response (Paper I) 
 to provide ultra-structural insights into the uptake of a cell-penetrating pep-
tide S413-PV and its analogues with reversed NLS and scrambled sequence. 
Specifically, to describe their association with the extracellular matrix and 
plasma membrane, the involvement of anionic glycosaminoglycans in these 
particular interactions and, consequently, their uptake pathways and locali-
zation in cells (Paper II) 
 to characterize the processes accompanying the cellular translocation of dif-
ferent representatives of the CPP families. In particular, to assess the 
changes in the intracellular calcium levels, triggering of the membrane repair 
response, and the ability of cells to overcome the stress caused by the 




3. METHODOLOGICAL CONSIDERATIONS 
The methods used in this study are described in detail in the respective papers 
and only brief comments on the chosen methods are given here. 
 
 
3.1. Cell cultures 
Throughout this study we have conducted experiments with four different cell 
lines. HeLa cells derived from human cervical adenocarcinoma were isolated in 
1951 and, since then, this is the the most widely used cell type in scientific 
research. Therefore, these cells have been employed in the field of CPP research 
numerous times as well, giving us a possibility to compare our results with the 
work of other groups but, moreover, to complement existing findings. We have 
performed experiments with HeLa cells in all the papers included in this thesis 
(Paper I–III). 
Wild-type Chinese hamster ovary cells (CHO-K1), in parallel with HeLa 
cells, were used in Paper I to assess whether CPPs exhibit analogous effects in 
different adherent cell lines. In addition, a wild-type CHO and a CHO mutant 
cell line (CHO pgsA-745) were included in Paper II. CHO pgsA-745 cells have 
a defect in the enzyme xylosyltransferase and, therefore, are not capable of 
expressing glycosaminoglycans (GAG) on the cell surface. It is believed that 
GAGs are the first interaction partners for CPPs with the plasma membrane and, 
because of this, we were able to evaluate how and if the lack of GAGs on the 
cell surface impacts CPP-membrane interactions and, consequently, the uptake 
pathway.  
Another cell line of human origin, Jurkat cells derived from human T 
lymphocytes, was used in parallel with HeLa cells in Paper III. Due to 
morphological and physiological differences between cell types, and because 
cellular susceptibility to injury and disruptions in the plasma membrane is 
largely determined by cell physiology and might therefore lead to different 
calcium influx patterns, we wanted to compare adherent cell lines with the ones 
growing in suspension.  
 
 
3.2. Cell-penetrating peptides and  
constructs with cargo 
In Paper I, we synthesized 15–17 amino acid long peptides derived from 
perforin, granulysin, and granzyme B. These proteins are natively involved in 
the human defense mechanism and are released by natural killer cells and 
cytotoxic T lymphocytes to protect the organism against viruses, bacteria, and 
cancer. At the same time, these proteins share some common characteristics 
with CPPs in their cellular uptake mode. Therefore, we aimed to test whether 
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the sequences responsible for the internalization of the whole protein could be 
employed as novel CPPs. To assess their cell-penetrating properties, we used 
two well-known CPPs for comparison. Specifically, MAP peptide was chosen 
because it is known to exhibit membrane disturbing activity and high 
cytotoxicity, and secondly, penetratin as a representative of a different CPP 
family with considerably lower toxic effects was also included. 
In Paper II, we studied the internalization of wild-type S413-PV and its ana-
logues with reversed NLS and scrambled sequence to understand the dif-
ferences responsible for their dissimilar uptake efficiency.  
In Paper III, we characterized the processes accompanying the cellular trans-
location of seven CPPs representing different CPP families: MAP and transpor-
tans (TP and its shorter analogue TP10) as highly efficient transport vectors that 
possess amphipathic characteristics and may cause membrane leakage; pene-
tratin and pVEC that are less membrane-active and exhibit amphipathic pro-
perties only under certain conditions; and finally, Tat-peptide and nona-arginine 
that consist of a high number of arginines and are unstructured in solution were 
studied.  
Even though in this thesis we have mainly focused on the internalization 
mechanism(s) of CPPs, it is acknowledged that the uptake pathway and, there-
fore, also cytotoxicity might change after the addition of a cargo molecule to the 
CPP. Different strategies have been used for conjugation of a payload to the 
peptide; for example, expression of a CPP-fusion protein in bacterial systems, 
or linkage by disulfide bond that will be cleaved in the reducing environment of 
the cytoplasm enabling the release of a cargo from the transport vector. 
However, the easiest and most convenient way is a non-covalent complexation 
of a cargo to a carrier peptide by simple co-incubation. This type of interaction 
can only occur in case of high affinity between the two molecules, such as 
binding of biotin to avidin. Avidin is a ~67 kDa tetrameric egg white 
glycoprotein with each monomer having one biotin binding pocket. Because 
avidin has a total of four potential biotin binding sites, we co-incubated 
biotinylated CPPs with avidin with 3:1 molar ratio. Under this condition, the 
protein would be semi-saturated and there is no free peptide in the solution to 
compete with the uptake of CPP-avidin complexes. 
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Table 1. Names and sequences of cell-penetrating peptides included in this thesis 
Peptide Sequence 
pPrF 82–98 (pPrF82) QRHVTRAKVSSTEAVAR-NH2 
pPrF 338–354 (pPrF338) ALRRALSQYLTDRARWR-NH2 
pGrL 68–82 (pGrL) NAATRVCRTGRSRWR-NH2 
pGrB 89–104 (pGrB) IMLLQLERKAKRTRAV-NH2 
S413-PV wild-type peptide (S413-PVwt) ALWKTLLKKVLKAPKKKRKVC-NH2 
S413-PV with reversed NLS (S413-PVrev) ALWKTLLKKVLKAVKRKKKPC-NH2 
S413-PV with scrambled sequence  
(S413-PVscr) 
KTLKVAKWLKKAKPLRKLVKC-NH2 











3.3. Calcium indicators 
Calcium ions are involved in many cellular processes and, therefore, numerous 
methods have been developed to measure Ca2+ concentrations in sub-cellular 
compartments and to analyze the changes in intracellular Ca2+ levels. Unfor-
tunately, like with a large amount of scientific questions, there is no ideal tech-
nique to measure Ca2+ concentrations in cells. In our studies we have used dif-
ferent techniques to analyze changes in intracellular Ca2+ concentration, and 
taken advantage of two different Ca2+ indicators – Fura-2-AM (Paper I) and 
Fluo-4-AM (Paper III). 
Fura-2 is a widely harnessed ratiometric fluorescent reporter that binds to 
free calcium ions, thus, allowing accurate measurement of intracellular calcium 
concentrations. Even though most of the calcium indicators are cell 
impermeable, we took advantage of the acetoxymethyl (AM) ester forms 
available nowadays. This type of modification gives the indicator the ability to 
passively diffuse across cellular membranes, and once inside the cells, the 
esterases remove the AM groups from the probe resulting in a cell-impermeant 
calcium sensitive dye. However, Fura-2 redistributes relatively easily to 
different sub-cellular compartments unequally and is prone to interact with 
proteins leading to possible misinterpretation of the data. Another limitation of 
Fura-2 is that this probe is not suited for experiments with confocal laser 
scanning microscopy (CLSM) and fluorescence activated cell sorting (FACS), 
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because it is difficult to alter excitation wavelength rapidly enough using this 
type of instrumentation.  
Mainly because of the above mentioned drawbacks, we employed a 
nonratiometric Fluo-4 in our later studies (Paper III). In addition, we lowered 
the dye loading temperature from 37 °C to room temperature to achieve a 
uniformly localizing probe, because it became evident that, in addition to cyto-
plasmic and nuclear distribution, at higher loading temperatures this indicator 
was to a great extent also accumulating in endosomal vesicles.  
  
3.4. Internalization of cell-penetrating peptides 
To study the uptake of CPPs or their constructs with cargo molecules, several 
techniques can be applied. Flow cytometry enables quantification of the amount 
of the fluorescently labeled peptides in live cells; however, it is not able to dis-
criminate the intracellular signal from the label bound to the outer leaflet of the 
plasma membrane. To eliminate the signal of peptide associated with the extra-
cellular side of the membrane, we used trypsin and trypan blue treatments. The 
first one should cleave non-internalized CPPs from the cell surface, however, 
the peptides might aggregate and/or be buried into the lipid bilayer making 
them hardly accessible to enzymatic digestion. Therefore, trypan blue was used 
to quench the residual fluorescence signal. 
 
3.4.1. Transmission electron microscopy 
To visualize the uptake and localization of the fluorescently labeled CPPs in 
cells, we have applied fluorescence microscopy. However, this was merely used 
for the overall estimation whether the CPPs exploit mainly endocytic pathways 
or are able to diffusely stain the cytoplasm. Nevertheless, a diffuse staining 
detected by CLSM does not give us information whether the CPPs were able to 
directly cross the barrier of the plasma membrane or were liberated from the 
endocytic vesicles after their internalization and, therefore, gained access to the 
cytoplasm of the cells.  
To get a more detailed insight into this matter and to characterize the uptake 
of CPPs on the ultra-structural level, we took advantage of the conventional 
transmission electron microscopy. Electron microscopy is not an extensively 
applied technique in the field of CPP research so far. On the other hand, 
electron microscopy is a powerful tool and provides resolution necessary for an 
unambiguous distinction whether CPPs associate first with the extracellular 
matrix or directly with the plasma membrane, what is the size and shape of the 
loci of initial contacts of CPPs with cells, which type of vesicles mediate the 
uptake, where are CPPs confined in relation to sub-cellular compartments, and 
the like. 
For electron microscopy, the cells were incubated with CPPs labeled with a 
1.4 nm Nanogold tag, fixed with 2.5% glutaraldehyde in cacodylate buffer and, 
thereafter, the Nanogold label on the peptide was magnified by silver 
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enhancement to enable detection of the particles. Finally, the specimen was 
processed for flat embedding into the epoxy resin for the best preservation of 
the morphology of cellular ultra-structure, and ultrathin sections were cut in 
parallel to the growth substrate.  
To analyze whether the CPPs associate preferentially with the glycosidic 
component of the cell surface, we used staining with ruthenium red, which was 
added to fixative to reveal cell surface regions rich in mycopolysaccharides. In 
addition, cells were treated with hyaluronidase to remove the hyaluronan 
strands from the cell surface. In order to assess the importance of plasma 
membrane fluidity and the role of classical endocytotic pathways, we performed 
experiments at 10 ºC, since the vesicular uptake should be blocked below 18 ºC. 
In parallel, we suppressed endocytosis by inhibiting the dynamin activity by 
pre-treating the cells with the drug dynasore. 
 
 
3.5. Visualization of the membrane repair response 
For the studies of the MRR activation, we first had to work out and optimize a 
fixation protocol that would not interfere with the integrity of the plasma 
membrane enabling us to detect the integral lysosomal protein (LAMP-2 – 
lysosome-associated membrane protein 2) on the cell surface to where, under 
normal conditions, it is not targeted. Therefore, we used fixation with 3% 
paraformaldehyde in a phosphate buffer for 30 min at the room temperature. 
This method avoids permeabilization of the cells in case the plasma membrane 
integrity is not challenged, however, if incubation with CPPs or CPP-cargo 
constructs induces destabilization of the lipid bilayer then a small quantity of 
antibodies against LAMP-2 is able to diffuse deeper into cells and visualize also 
a fraction of lysosomes inside the cells. Nevertheless, the pool of lysosomes 
inside the cells is considerably bigger, and the fixation and permeabilization of 
cells with methanol enabled the detection of the total amount of LAMP-2 in 
cells that was used as a positive control.  
Furthermore, after the fixation and staining of cells with fluorescently 
labeled antibodies, it became evident that two different patterns of LAMP-2 
occur – cell surface LAMP-2 staining and lysosomal LAMP-2 staining. The 
first one is visualized as a “network” of small punctuate staining on the plasma 
membrane; on the other hand, lysosomes are marked as much bigger structures 
mostly closer to the perinuclear region. In addition, it should be mentioned that 
from the whole population ~10% of the cells are always weaker and/or damaged 
per se and, therefore, have a less intact plasma membrane and exhibit more 
prominent staining of the cell center. This phenomenon was included in the 
figure representing the MRR of CPPs in Paper I (figure 6 in Paper I), and might 
therefore lead to minor misinterpretation of the data presented. However, we 
have corrected this in Paper III, where we did not incorporate the figures 
demonstrating this type of “background” (figure 3 in Paper III).  
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4. RESULTS AND DISCUSSION 
4.1. Destabilization of the plasma membrane  
by cell-penetrating peptides activates the membrane 
repair response (Paper I) 
Three proteins involved in target cell apoptosis – perforin, granulysin, and 
granzymes – share some common features in the uptake mode of cell-pene-
trating peptides (Bird et al., 2005; Ernst et al., 2000; Keefe et al., 2005). More-
over, perforin is known to form small pores in the plasma membrane that in turn 
induces the influx of calcium ions into cells and, subsequently, activates a mem-
brane repair response (MRR) (Keefe et al., 2005). Since some CPPs are able to 
directly penetrate across the plasma membrane (Fretz et al., 2007; Tünnemann 
et al., 2006) and massive accumulation of CPPs on the cell surface might desta-
bilize the lipid membrane, we hypothesized that internalization of CPPs might 
also induce the influx of Ca2+ and trigger the MRR. 
 
 
4.1.1. Interaction of novel cell-penetrating sequences  
with the cell surface and internalization into cells 
It has been previously demonstrated that shorter cationic sequences from 
perforin, granulysin, and granzyme B contribute to the cytotoxicity and/or 
uptake of the respective proteins (Bird et al., 2005; Li et al., 2005; Liu et al., 
1995). Therefore, the sequences of peptides were taken from the full-length 
proteins and synthesized to assess their cell-penetrating properties and 
propensity to destabilize cellular membranes. The uptake efficiency of four 
novel peptides (pPrF82, pPrF338, pGrB, and pGrL) was analyzed by FACS and 
compared with two well-known CPPs (MAP and penetratin). All studied 
peptides were taken up by cells, although the new peptides were not as efficient 
as penetratin or MAP. CLSM results confirmed the internalization of the novel 
CPPs, which localized in endosomes that were visible as distinct punctuate 
structures, and also diffusely in the cytoplasm. 
To characterize the association of pGrB (peptide derived from granzyme B) 
with the plasma membrane and its distribution inside the cells in detail, we 
employed electron microscopy. Incubation of HeLa cells with the nanogold-
tagged (1.4 nm) peptide revealed that pGrB associated with the cell surface 
preferentially at protrusions. The interaction of the peptide with the plasma 
membrane induced the formation of spherical structures with an electron-dense 
background, which contained several peptide molecules per cluster. At low 
concentration (0.5 µM), the peptide assemblies were able to insert into the 
plasma membrane and translocate into the cortical cytoplasm but not deeper 
inside the cells. However, at higher peptide concentration (2.5 µM), pGrB 




4.1.2. Uptake of cell-penetrating peptides induces  
the influx of calcium ions 
Our electron microscopy data implicated that the peptides induce changes in the 
membrane morphology and, therefore, we wanted to further assess whether the 
studied peptides are able to induce the influx of calcium ions. The cells were 
loaded with Ca2+ indicator Fura-2, followed by the treatment with peptides for 5 
or 30 min at different concentrations. During the first 5 min, a transient and 
concentration-dependent influx of Ca2+ was observed with penetratin and pGrB 
in HeLa cells, although the Ca2+ level did not return to the basal level. MAP 
induced a continuous influx of Ca2+ that was sustained throughout the measure-
ment; however, the influx of Ca2+ was not as high as with the ionophore 
ionomycin that was used as a positive control. The Ca2+ influx was not only 
concentration dependent but also followed the uptake efficiency of the peptide. 
Namely, MAP induced an influx of Ca2+ at lower peptide concentrations than 
penetratin, and penetratin at lower concentrations than pGrB.  
 
 
4.1.3. Cell-penetrating peptides trigger lysosomal  
exocytosis and membrane repair response 
Influx of Ca2+ into the cells activates several processes, including lysosomal 
exocytosis and the MRR. To quantify the lysosomal exocytosis caused by the 
CPPs, the influence of penetratin and MAP on the activity of the lysosomal 
protein β-hexosaminidase in cell supernatant was assessed. An increase in the 
enzyme activity could be deteced already at 100 nM concentrations of 
penetratin and MAP after the incubation of HeLa or CHO-K1 cells with these 
CPPs for 5 min. The β-hexosaminidase activity was concentration-dependent 
and, as expected, MAP was more potent in promoting lysosomal exocytosis. 
Analogously with other forms of exocytosis, lysosomes are subject to a so-
called “kiss-and-run” events, which after stronger stimulation leads to the 
complete fusion of vesicles with the plasma membrane (Jaiswal et al., 2002; 
Zhang et al., 2007). Our results showed that the increase in intracellular  
Ca2+ levels caused by the peptides was well correlated with the higher  
β-hexosaminidase activity in the extracellular medium, indicating that influx of 
Ca2+ could be responsible for the stimulated β-hexosaminidase release. 
To assess whether the extracellular Ca2+ concentration affects the efflux of  
β-hexosaminidase, cells were incubated in a buffer containing peptides and 
5 mM calcium. Under these conditions, extracellular enzyme activity was signi-
ficantly increased after treatment of penetratin, both in HeLa and CHO-K1 cells. 
into the cortical cytoplasm was detected. In addition, the peptide seemed to 
interfere with the ordered packing of the membrane phospholipids because the 
plasma membrane became less distinct as visualized by electron microscopy. 
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Even though increased β-hexosaminidase activity was detected with MAP in 
CHO-K1 cells, no significant increase over the basal level could be detected 
with this CPP in HeLa cells. However, the fraction of lysosomes available for 
the plasma membrane docking is not known and these discrepancies might be 
attributed to the differences between cell types. Specifically, more membrane-
active MAP peptide might have facilitated the maximum fusion of lysosomes in 
HeLa cells already at normal concentration of the extracellular calcium. 
In addition, if the peptides are able to cause a Ca2+ influx sufficient enough 
to trigger the MRR, lysosomes should be translocated to the plasma membrane. 
The fusion of the lysosomal membranes with the plasma membrane can be 
detected by the exposure of the lysosomal protein LAMP-2 on the cell surface. 
First, we confirmed that the full-length protein perforin was able to induce the 
activation of the MRR in our experimental set-up in a concentration-dependent 
manner. After that, we analyzed if the CPPs are also able to exert analogous 
effects. Our results with fluorescence microscopy demonstrated that MAP, 
peptide known to interfere with the plasma membrane integrity at low 
concentrations (Hällbrink et al., 2001), stimulated targeting of LAMP-2 to the 
plasma membrane in some cells even at 0.5 µM concentration. Raising the 
concentration of MAP to 1 µM led to the accumulation of the lysosomal protein 
to the cell surface in all cells in the population. Analogously to perforin, higher 
concentrations of MAP induced the translocation of LAMP-2 to the plasma 
membrane to a lesser extent and exhibited a more pronounced staining of the 
cell center. This effect is probably observed because of the substantial influx of 
Ca2+ that becomes toxic to cells. Therefore, cells die before they are able to 
reseal the damaged plasma membrane regions and, since the plasma membrane 
has lost its barrier function, antibodies against LAMP-2 visualize also 
lysosomes inside the cells, in addition to the LAMP-2 exposed on the cell 
surface.  
Penetratin that is considered less toxic to cells, induced the appearance of 
LAMP-2 on the plasma membrane of cells at markedly higher concentrations. 
Translocation of lysosomes remained undetectable up to 3 µM and was 
negligible at 5 µM; however, starting from 10 µM concentration, the activation 
of the MRR was observed. Because the influx of calcium ions triggers the 
resealing of the injured plasma membrane within seconds, this would explain 
why no leakage of cytoplasmic contents after the uptake of CPPs is detected, 
even though there appear to be membrane disturbances caused by the peptides. 
 
  
4.1.4. Extracellular calcium concentration affects  
the uptake efficiency of cell-penetrating peptides 
Since the influx of calcium ions was detected after the treatment of cells with 
CPPs, it was important to investigate whether the concentration of Ca2+ in the 
medium surrounding the cells affected the uptake of peptides. If the peptides 
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activate the resealing of the plasma membrane, the uptake of CPPs should most 
probably increase if no Ca2+ is present outside the cells because the MRR can-
not be activated. Moreover, if the Ca2+ concentration is increased in the extra-
cellular environment, it might lead to a diminished internalization of CPPs 
because of a more efficient plasma membrane repair under these conditions.  
Based on this hypothesis, we incubated the cells with fluorescently labeled 
peptides in buffers with different Ca2+ concentrations (0–5 mM calcium con-
centration) and analyzed the cell lysates by high-performance liquid chromato-
graphy. Penetratin and pGrB were more efficiently taken up by cells when 
incubated in a buffer without Ca2+, which was expected because there was no 
Ca2+ to activate the MRR. In the presence of excess Ca2+, the uptake of these 
peptides was significantly reduced in a concentration-dependent manner. 
However, it should be mentioned that the decrease in the internalization 
efficiency of CPPs could also be a consequence of the increased concentration 
of the positive calcium ions in the extracellular environment that compete with 
CPPs for electrostatic interactions with the proteoglycans. Furthermore, it has 
also been shown that extracellular calcium ions can increase the stability of 
membranes (Kim and Southard, 1999) and, therefore, hamper the uptake of 
CPPs. Nevertheless, uptake of MAP was not affected by the concentration of 
Ca2+ in the surrounding medium. 
 
 
4.2. Efficient uptake of S413-PV peptides by cells  
is facilitated by the formation of nanoparticle-like 
structures (Paper II) 
In paper II, we focused on the characterization of the membrane interactions, 
the subsequent uptake pathways, and the intracellular localization of S413-PV 
peptides. S413-PVwt and S413-PVrev are shown to be efficiently taken up by 
cells through an apparently rapid receptor- and energy-independent process and, 
less efficiently, through clathrin-mediated endocytosis (Mano et al., 2006; 
Mano et al., 2005). In addition, biophysical experiments have revealed that 
S413-PV peptide acquires an helical conformation upon interaction with target 
membranes and is partially inserted into the hydrophobic environment of the 
lipid bilayer (Mano et al., 2007). However, these properties are not fully shared 
by its analogue with a scrambled sequence (S413-PVscr).  
 
 
4.2.1. Interaction of S413-PV peptides  
with the plasma membrane 
Incubation of HeLa cells with different concentrations of S413-PVwt-nanogold 
conjugates (0.1–10 μM peptide concentration) led to the assembly of peptides 
into spherical structures that accumulated on the plasma membrane. These 
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clusters were detectable by electron microscopy after already 10 min of addition 
of 0.1 μM peptide to the cells. However, at this low concentration the peptide-
containing structures were small and contained only a few gold particles per 
cluster. Raising the peptide concentration (0.5–1 μM) led to the assembly of 
structures that had a regular shape and a relatively uniform size of about 80 nm 
reminiscent of the nanoparticles (diameter 79.8 ± 16.4 nm). The assembly of the 
wild-type peptide into nanoparticles was rather prevailing, but still a small 
fraction of peptides bound to the extracellular matrix without the formation of 
these distinct electron-dense spherical structures and, at higher peptide 
concentrations (>1 μM), assembly into bigger aggregates was also evident.  
S413-PV peptide with the reversed NLS was able to form nanoparticle-like 
structures as well; however, these were moderately bigger and more variable in 
size and shape. Namely, quantitative analysis revealed that the average size of 
the particles formed by S413-PVrev after 30 min incubation with 1 μM peptide 
was about 142 nm (diameter 142.6 ± 22.7 nm). In contrast, we found that the 
peptide with the scrambled sequence was not able to assemble into regular 
nanoparticle-like structures like detected with the wild-type and the reverse 
NLS peptides. S413-PVscr typically formed bigger irregular aggregates on the 
surface of cells indicating that not only amino acid composition, but also their 
position within the peptide influences the mode of interaction with the plasma 
membrane.  
The nanoparticle-like structures of the wild-type and the reversed NLS 
peptides were formed only in the presence of cell membranes, since the 
incubation of peptides in the cell culture medium with or without serum did not 
lead to the assembly of this type of particles. In addition, we ruled out the 
possibility that these spherical assemblies were formed because of the clustering 
of the Nanogold tag, since Nanogold itself was not able to associate with the 
cell surface and, furthermore, no aggregation of the gold particles was detected. 
These results clearly indicate that a direct interaction with the cell surface or a 
specific environment is essential for the formation of the peptide nanoparticles.  
 
 
4.2.2. Cell surface glycosaminoglycans play a role  
in the formation of peptide nanoparticles 
The electron microscopy results demonstrated that the peptide nanoparticles had 
an electron-dense background. First, taking into account the fact that binding of 
the polycationic compounds to the HSPGs is able to induce the clustering and 
the concentration of the ligand to the cell surface as dense aggregates before 
their internalization (Ziegler et al., 2005; Ziegler and Seelig, 2008); and 
secondly, because our experiments showed that after the staining of the 
extracellular matrix with ruthenium red, a polycationic cytochemical dye for 
mucopolysaccharides, the electron density of S413-PV particles’ background 
was markedly increased, we wanted to further assess the incorporation of the 
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GAGs into the CPP nanoparticles. Therefore, we analyzed the association of 
S413-PVwt with the cell surface of wild-type (CHO-K1) and mutant CHO pgsA-
745 cells that are defective in GAG biosynthesis (Esko 1985) and lack specific 
GAGs on the core protein of proteoglycans. In wild-type CHO cells, the peptide 
accumulated extensively to the plasma membrane of cells and formed 
nanoparticles with similar size and shape as detected in HeLa cells. Surprisingly, 
these particles were also present at the surface of CHO pgsA-745, however, the 
amount of the peptide particles associating with the plasma membrane was 
markedly reduced in comparison to the wild-type CHO. Thus, the formation of 
nanoparticles is not only dependent on the presence of GAGs (e.g. heparan 
sulfate) on the cell surface.  
Furthermore, the treatment of the mutant CHO cells with hyaluronidase, an 
enzyme that specifically cleaves glycosidic bonds in hyaluronic acid and 
thereby removes the hyaluronan strands from the cell surface, almost abolished 
the formation of S413-PV nanoparticles. Even though a negligible fraction of the 
nanoparticles were still able to assemble on the cell surface and internalize into 
the cells, this data suggest that the glycosidic component is required for the 
formation of the peptide nanoparticles and that hyaluronic acid containing 
proteoglycans might contribute to this phenomenon.  
 
 
4.2.3. S413-PV nanoparticles interfere with the ordered  
packing of the plasma membrane and enter the cells 
The S413-PVwt and S413-PVrev peptides preferentially associated with specific 
areas of the plasma membrane and upon a longer incubation, the nanoparticles 
continued to accumulate to these particular regions. Accumulation of the 
peptides interfered with the ordered packing of the lipid bilayer making the 
distinct ultra-structure hardly detectable by electron microscopy. In parallel 
with the interaction of the S413-PVwt particles with the plasma membrane and 
the destabilization of the lipid bilayer, these particles inserted into the cortical 
cytoplasm and induced the formation of small vesicles (diameter 50–100 nm). 
Our electron microscopy results indicate that the formation of the small and 
regular peptide nanoparticles was in good correlation with their ability to enter 
cells. Namely, the peptides forming regular structures (S413-PVwt and S413-
PVrev) are more efficiently taken up by cells compared to S413-PVscr that 
forms large irregular aggregates on the cell surface. In addition, the plasma 
membrane of cells becomes less distinct upon interaction with S413-PVwt or 
S413-PVrev but not with S413-PVscr. These observations could explain earlier 
reports (Mano et al., 2007; Mano et al., 2006) demonstrating that the cellular 
uptake of the scrambled peptide was significantly less efficient than the 
internalization of S413-PVwt and S413-PVrev. 
After the peptide was taken up by cells, the nanoparticles were found in 
rosette-like structures that morphologically resemble to caveosomes and, at later 
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time points, they also resided in MVBs. MVBs are usually destined to fuse with 
lysosomes and eventually the content of these endosomes is degraded in the 
acidic environment. However, the peptide nanoparticles retained their regular 
organization within the endosomes for at least 4 hours and in some cases these 
particles were relatively intact even after 24 hours. These data suggest that the 
degradation of the nanoparticles is inhibited or drastically slowed down that 
might be a consequence of the strong association of the cationic peptides with 
the anionic GAGs. Moreover, continuous uptake of S413-PV peptides during 24 
hours impaired the membrane integrity of the peptide-containing vesicles and 
resulted in the escape of peptides into the cytosol, indicating that the high local 
concentration of the peptide is able to destabilize also cellular membranes. 
 
 
4.2.4 Cellular uptake of S413-PV peptides is hampered  
by dynamin inhibition and low temperature,  
but does not abolish the vesicular uptake of S413-PV 
Since the uptake of S413-PV peptides involves the formation of small vesicles 
and the peptide nanoparticles are also found inside endocytic compartments, 
such as caveosomes and MVBs, it is possible that these peptides exploit well-
know endocytic pathways to gain entry into cells. Therefore, we examined the 
effect of dynasore on the translocation efficiency of S413-PVwt. Dynasore is an 
inhibitor of the dynamin GTPase activity that blocks the formation and fission 
of vesicles in most endocytic pathways (Macia et al., 2006). Inhibition of the 
dynamin activity decreased the uptake of S413-PVwt, however, the peptide 
nanoparticles were still able to assemble, insert into the plasma membrane, and 
induce the formation of small vesicles.  
Next, we analyzed the impact of lowering the incubation temperature below 
18 °C that decreases the plasma membrane fluidity and inhibits endocytosis. At 
low temperature (10 °C), despite the markedly decreased amount of surface-
bound peptides, the vesicular uptake of S413-PVwt and both of its analogues 
was significantly reduced but not completely blocked. A small fraction of the 
peptide was found in small vesicles or bigger vesicular structures, which located 
in the close proximity of the plasma membrane but not deeper in the cells. We 
can conclude that endocytic pathways are involved in the internalization of the 
S413-PV peptides, however, dynamin is not necessarily required for the fission 
of these vesicles. 
 
 
4.2.5. S413-PV peptides activate the membrane repair response 
at higher peptide concentrations than  
required for the efficient cellular entry of the peptide 
In paper I, we demonstrated that the accumulation of some CPPs on the cell 
surface induces disturbances in the ordered packing of the lipid bilayer and, 
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consequently, the plasma membrane becomes less distinct (Palm-Apergi et al., 
2009). These particular peptides were also able to trigger the membrane 
resealing mechanism called membrane repair response (MRR). Since our 
electron microscopy results revealed that the association of the S413-PVwt and 
the S413-PVrev particles with the cell surface complicates the detection of the 
plasma membrane at the accumulation sites, we further analyzed the ability of 
the S413-PV peptides to activate the MRR. The fluorescence microscopy results 
demonstrated that S413-PV peptides induced the MRR, but this mechanism was 
activated at higher peptide concentrations than necessary for the efficient uptake 
of S413-PVwt and S413-PVscr. We also observed that the appearance of the 
lysosomal protein LAMP-2 on the plasma membrane correlated with the size 
and heterogeneity of the S413-PV nanoparticles. Namely, the S413-PV with the 
reversed NLS that formed bigger and more heterogeneous nanoparticles 
(diameter ~142 nm) triggered the MRR at lower peptide concentration 
compared to the wild-type peptide that formed a homogeneous population of 
small regular particles (diameter ~80 nm). Furthermore, the S413-PV with the 
scrambled sequence assembled on the cell surface into large irregular 
aggregates and associated with the cells without disturbing the integrity of the 
lipid bilayer, and as expected, induced the activation the MRR in cells at 2–3 
fold higher peptide concentration than its analogues.  
 
 
4.3. Amphipathic cell-penetrating peptides induce  
the influx of calcium ions and activate several 
downstream responses (Paper III) 
In paper III, we mainly focused on the detailed analysis of the seven representa-
tives of the different CPP families regarding their propensity to induce the 
influx of extracellular calcium ions into cells and the activation of downstream 
responses, such as blebbing of the plasma membrane, lysosomal exocytosis, and 
MRR. In addition, a new aspect – the ability of the cells to deal with the 
elevated intracellular Ca2+ levels – was thoroughly assessed.  
 
 
4.3.1. Primary amphipathic cell-penetrating peptides  
induce calcium influx in cells starting from low peptide 
concentrations 
To evaluate whether the studied CPPs induce membrane disturbances and a 
subsequent influx of Ca2+ into cells, we employed two different cell lines and 
methods. First, we performed the intracellular Ca2+ measurements with Jurkat 
cells using a fluorescence plate reader. This gave us a possibility to 
quantitatively compare the increase of Ca2+ induced by the CPPs to the effect of 
ionophore – ionomycin – that was used as a positive control. Secondly, in order 
39 
to analyze the dynamics of Ca2+ concentration in single cells as well as on a 
subcellular level, we performed the experiments in HeLa cells applying CLSM.  
Our results with fluorometer revealed that MAP was the most membrane-
active peptide, inducing the Ca2+ influx into Jurkat cells in a concentration- and 
time-dependent manner. In our experimental set-up, the first effects were 
detected starting from 0.5 µM peptide concentration after 5 min incubation, and 
the highest elevation of Ca2+ signal (~85% as compared to ionomycin) was 
induced with 5 µM MAP after 30 min incubation.  
TP was less membrane-active and first effects in Jurkat cells were detected 
starting from 3 µM TP after 5 min incubation. The TP-induced Ca2+ influx was 
continuous at lower peptide concentrations; however, 5 µM TP elevated the 
Ca2+ concentration up to 60% where a plateau seemed to be reached. A shorter 
analog of transportan, TP10, induced a detectable Ca2+ influx at even higher 
concentrations than TP. Namely, 3–5 µM TP10 caused a 35% increase after 
30 min incubation, and the Ca2+ level reached up to 50% of the maximum signal 
at a 10 µM concentration.  
Our results with CLSM demonstrated that the observed changes at lower 
peptide concentrations were a result of a substantial Ca2+ influx into a subpopu-
lation of cells rather than a minor uniform increase in the whole cell population. 
However, the increase in the concentration of the CPPs led to the elevation of 
intracellular Ca2+ concentration, both in the cytoplasm and nucleus, in the whole 
population of cells.  
In addition, the incubation of HeLa cells with the primary amphipathic CPPs 
induced occasional blebbing of the plasma membrane that was dependent on 
both the concentration of used CPP and time. For example, 3 µM MAP 
triggered blebbing of the plasma membrane after 30 min incubation, however, 
treatment of cells with 5 µM MAP led to the formation of blebs already after 8 
min. In general, the plasma membrane blebbing was observed substantially 
faster at higher peptide concentrations with all the primary amphipathic CPPs 
tested.  
Blebbing of the plasma membrane has been observed during physical and 
chemical stress, and is usually preceded by an elevation of the intracellular Ca2+ 
that has to rise over ~ 300 nM concentration (Smith et al., 1991). Our results 
imply that, in fact, a certain intracellular Ca2+ concentration has to be reached 
and retained before the depolymerization of the actin cortex takes place and, as 
a consequence, big stable blebs of the plasma membrane form. 
 
 
4.3.2. Secondary amphipathic cell-penetrating peptides  
induce calcium influx in cells starting from  
higher peptide concentrations 
In contrast, penetratin and pVEC triggered the influx of Ca2+ into Jurkat cells at 
markedly higher concentrations than primary amphipathic CPPs, and their 
40 
effects were observed starting from 20 µM concentrations after 5 min treatment. 
Surprisingly, a prolonged incubation did not increase the Ca2+ influx and the 
detected fluorescence signals remained at the comparable levels for 30 min after 
the addition of these CPPs. In analogy with the results obtained in Jurkat cells, 
incubation of HeLa cells with penetratin and pVEC exerted similar effects. An 
increase in the Ca2+ levels and, thus, a diffuse staining of the cytoplasm and 
nucleus with the calcium indicator in approximately 15% of cells was detected 
after 5 min starting from 20 µM concentrations. A longer incubation (30 min) 
with these peptides did not have an additional effect on the Ca2+ levels in the 
cells.  
In case of pVEC and penetratin, the formation of big stable blebs was not 
detected during a 30-min incubation even at the highest used concentration 
(20 µM), suggesting that although the intracellular Ca2+ concentration was in-
creased, its level did not reach the threshold necessary for the depolymerization 
of the cortical actin and the disruption of interactions between the plasma mem-
brane and the cytoskeleton.  
 
 
4.3.3. Non-amphipathic cell-penetrating peptides  
do not induce calcium influx in cells 
The arginine-rich peptides, Tat-peptide and nonaarginine, did not influence the 
intracellular Ca2+ levels in Jurkat cells even at very high peptide concentrations. 
The fluorescence of the calcium indicator remained at the basal levels 
throughout the measurement in the used concentration range from 5 to 50 µM. 
In addition, CLSM results corroborated that Tat-peptide and nonaarginine did 
not affect the intracellular Ca2+ concentration in HeLa cells. Even 30 min after 
the addition of 50 µM peptides, no increase in the fluorescence signal was 
observed. Moreover, since these CPPs did not modulate the intracellular Ca2+ 
concentrations in Jurkat and HeLa cells in our experiments, blebbing of the 
plasma membrane was not detected. It has been shown that Tat-peptide and 
nonaarginine are unstructured in solution and, therefore, less prone to stably 
associate with membranes (Ziegler et al., 2003). This might explain why they 
do not induce the Ca2+ influx into cells even at very high concentrations.  
 
 
4.3.4. Calcium influx induced by cell-penetrating  
peptides triggers lysosomal exocytosis and  
the plasma membrane repair response 
To corroborate the fusion of lysosomes with the plasma membrane and the 
release of their content, we measured the efflux of the lysosomal enzyme β-
hexosaminidase into the extracellular medium. Among the studied CPPs, MAP 
was the most potent in inducing the release of the lysosomal content followed 
by TP, TP10, penetratin, and pVEC. On the other hand, Tat-peptide and 
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nonaarginine, did not increase the activity of β-hexosaminidase in the extra-
cellular environment.  
In order to further characterize the effect of CPPs on the integrity of the 
plasma membrane, we analyzed their potency to trigger the MRR. We have 
previously demonstrated that MAP induced the exposure of LAMP-2 on the 
plasma membrane at low concentrations (even below 1 µM), whereas with 
penetratin a significant effect was detected starting from 20 µM concentration 
(Palm-Apergi et al., 2009). In this study, the plasma MRR was in very good 
correlation with the cytosolic Ca2+ concentration induced by the CPPs. The 
fluorescence microscopy experiments demonstrated that 1 µM TP did not 
induce a Ca2+ influx, nor did it trigger the MRR. On the other hand, raising the 
concentration to 3 µM or 5 µM induced the appearance of LAMP-2 on the 
plasma membrane in approximately 30% or 80% of cells in the observed 
population, respectively. The pVEC peptide, in contrast, stimulated the 
translocation of LAMP-2 to the cell surface in approximately 20–30% of cells 
at 20 µM concentration. Our results demonstrate that the targeting of lysosomes 
to the cell periphery and the associated fusion events, as well as the release of  
β-hexosaminidase, were triggered by the primary amphipathic CPPs (MAP, TP, 
TP10) at markedly lower peptide concentrations compared to the secondary 
amphipathic ones (pVEC and penetratin). In concordance with the Ca2+ influx 
assays, Tat-peptide and nonaarginine did not induce the fusion of lysosomes 
with the plasma membrane or the release of β-hexosaminidase from the cells.  
 
 
4.3.5. Coupling of a cargo protein to cell-penetrating peptides 
decreases the membrane interfering activity of the peptides 
It has been suggested that the attachment of a cargo molecule to the CPP may 
alter the uptake mode of the CPP (El-Andaloussi et al., 2007) and its cytotoxic 
effects. Therefore, we assessed the induction of the MRR by amphipathic CPPs 
after complexation with a ~67 kDa cargo protein avidin. 
Our results with CLSM showed that MAP-avidin and TP-avidin complexes 
were both less potent in the induction of the MRR compared to the respective 
peptides alone. For example, the MAP-avidin complexes triggered the MRR 
only in a few cells at 1 μM peptide concentration; however, the exposure of 
LAMP-2 on the plasma membrane was detectable in more than 80% of the cells 
after the incubation with 5 μM MAP-avidin complexes. Since similar effects 
with MAP alone were detected with ~2-fold lower peptide concentrations 
(Palm-Apergi et al., 2009), we can conclude that the attachment of avidin to a 
biotinylated CPP drastically reduces the membrane disturbing activity of the 
peptide. An analogous effect where coupling of a cargo protein reduced the 





4.3.6. Cells can overcome the stress caused  
by the uptake of cell-penetrating peptides 
Significant elevation of the cytoplasmic Ca2+ is toxic to the cells; however, the 
activation of different damage control mechanisms might help the cells to 
restrain the uncontrolled influx of Ca2+ ions and to restore the ionic homeostasis. 
To assess this hypothesis, the viability of Jurkat cells was quantified by flow 
cytometry using a double-staining with annexin V and DAPI 24 hours after the 
treatment with peptides. As expected, MAP was the most toxic peptide and 
induced apoptosis or necrosis of cells in a concentration-dependent manner. 
Transportans were considerably less toxic to cells; and, penetratin induced 
apoptotic or necrotic events only in a small population of cells at the highest 
used concentration (20 μM). The viability of the cells stayed at a comparable 
level with the untreated cells after incubation with 20 μM pVEC, 50 μM Tat-
peptide, and 50 μM nonaarginine.  
To assess the barrier function of the plasma membrane of HeLa cells, we 
analyzed the uptake of DAPI to the cells after the challenge with the highest 
concentrations of TP. After a 30-min incubation with 5 μM TP only a few cells 
were permeable to DAPI and with 10 μM TP ~20% of cells became permeable 
to DAPI. Taken together, these results demonstrate that Jurkat and HeLa cells 
are able to replace the damaged plasma membrane regions and overcome the 
overload of cytosolic Ca2+ to a considerable extent. This is in good correlation 
with the earlier studies with the bacterial toxin streptolysin O which showed 
that the MRR functions effectively if the intracellular Ca2+ concentration stays 




The plasma membrane of cells forms an essential barrier between the extra- and 
intracellular milieu that, amongst many other functions, protects cells from the 
detrimental external influences. At the same time, the barrier function of the 
membrane is the major obstacle in therapeutics and biotechnology, since many 
promising bioactive compounds are not able to traverse lipid bilayers. To over-
come this drawback, a class of specific transport vectors that gain access into 
the cell interior and mediate the transport of otherwise impermeable 
molecules – cell-penetrating peptides – can be utilized. Even though their 
potential as efficient carrier peptides has been demonstrated repeatedly, the 
uptake mechanisms of CPPs are still not explicitly specified. It is known that 
certain CPPs are able to destabilize the plasma membrane; however, it is not 
clear how cells deal with the disturbances of the cell surface. Therefore, we 
focused on the internalization pathways of CPPs; more precisely, we 
characterized the association of CPPs with the cell surface and the subsequent 
uptake on the ultra-structural level by transmission electron microscopy. The 
potential membrane destabilization effects of CPPs were assessed by the 
measurement of intracellular calcium concentrations with a fluorescence plate 
reader. In addition, sub-cellular calcium dynamics and downstream responses 
(e.g. lysosomal exocytosis and membrane repair response) were studied by 
confocal laser scanning microscopy. 
 
The main results of this study can be concluded as follows: 
1. Novel CPP sequences derived from proteins perforin, granulysin, and 
granzyme B are all taken up by cells, although the new peptides are not as 
efficient as penetratin or MAP (Paper I) 
2. pGrB and S413-PV peptides induce changes in morphology of the plasma 
membrane, since they interfere with the ordered packing of the membrane 
phospholipids (Paper I and II) 
3. Membrane-active CPPs induce disturbances in the plasma membrane suffi-
cient enough to cause the influx of calcium ions, triggering the exocytosis of 
lysosomes, and activating the membrane repair response (Paper I–III) 
4. Wild-type S413-PV peptide and its analogue with reversed NLS form nano-
particle-like structures, and efficiently enter the cells via a vesicular pathway 
that is partially dynamin-independent and is not abolished by low tempera-
ture (Paper II) 
5. Glycosidic component of the cell surface is required for the formation of  
S413-PV peptide nanoparticles, and the hyaluronic acid containing 
proteoglycans might contribute to this phenomenon (Paper II) 
6. S413-PV peptides induce the membrane repair response; however, this 
mechanism is activated at higher peptide concentrations than necessary for 
the efficient uptake of S413-PVwt and S413-PVscr (Paper II) 
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7. Based on the interaction with the plasma membrane, the induction of the 
calcium influx, and downstream responses, three subgroups of CPPs can be 
distinguished (Paper III):  
a. primary amphipathic CPPs that affect the plasma membrane integrity, 
induce influx of calcium, and activate downstream responses starting 
from low micromolar concentrations;  
b. secondary amphipathic CPPs that induce calcium influx in cells starting 
from higher peptide concentrations than necessary for their efficient 
internalization (≥10 μM); 
c. non-amphipathic CPPs that do not evoke any changes at relevant 
concentrations (<50 μM) 
8. Influx of calcium ions induced by CPPs triggers the plasma membrane repair 
response that helps cells to overcome the stress caused by the uptake of 
CPPs (Paper III) 
9. Coupling of a cargo protein to CPPs decreases the membrane interfering 
activity of peptides (Paper III)  
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SUMMARY IN ESTONIAN 
Plasmamembraani barjääri ületamine: amfipaatsete rakku 
penetreeruvate peptiidide sisenemine põhjustab kaltsiumi 
sissevoolu ja rakuliste vastuste aktiveerimise 
Rakkudesse penetreeruvad peptiidid (RPP-d) on lühikesed (5–40 aminohappe 
pikkused), loodusliku või sünteetilise päritoluga spetsiifilised transportpeptiidid, 
mis hõlbustavad märkimisväärselt bioaktiivsete molekulide sisenemist rakku-
desse. Selliste vektorpeptiididega on rakkudesse viidud väga erinevaid lastmole-
kule (näiteks oligonukleotiide, peptiide, valke, halvasti imenduvaid ravimeid, 
nanopartikleid jne) ning positiivseid tulemusi on saadud nii in vitro kui ka in 
vivo katsetes. RPP-sid kirjeldati algselt kui ühendeid, mis võivad liikuda läbi 
plasmamembraani raku sisemusse sõltumata endotsütoosist ja teistest raku ener-
giat nõudvatest protsessidest. Praeguseks on jõutud arusaamale, et RPP-de 
sisenemise mehhanism(id) on tegelikkuses palju rohkem raku füsioloogilistest 
teguritest tulenev protsess ning täpne mehhanism(id) ja paiknemine rakus võib 
sõltuda peptiidi ja lastmolekuli füüsikalis-keemilistest omadustest, kontsentrat-
sioonist, rakutüübist ning mitmetest teistest teguritest. RPP-d ei kasuta 
rakkudesse sisenemiseks plasmamembraanil olevaid retseptorvalke, vaid 
seonduvad rakupinnal negatiivselt laetud plasmamembraani komponentidega, 
eelistades arvatavasti proteoglükaane. Sellest tulenevalt peetakse sisenemise 
seisukohalt oluliseks eelkõige peptiidide positiivset laengut. Kuigi viimase paari 
aasta jooksul on tõendust leidnud endotsütoosi suurem osatähtsus 
peptiidide/peptiid-lastmolekuli rakku sisenemisel, on samas näidatud, et 
kõrgemal kontsentratsioonil paikneb peptiid difuusselt tsütoplasmas ja on 
võimeline rakkudesse sisenema otse läbi plasmamembraani. Antud peptiidide 
vähene toksilisus, ühtlane sisenemise saagis ja suhteliselt suur efektiivsus 
lubavad pidada RPP-dega vahendatud transporti perspektiivseks alternatiiviks 
elektroporeerimisele, lipofektsioonile ja teistele invasiivsetele meetoditele, mida 
on seniajani kasutatud makromolekulide rakudesse sisestamiseks. 
Teadaolevalt „sukelduvad” mõned RPP-d osaliselt rakumembraani, mis võib 
kaasa aidata nende RPP-de efektiivsemale sisenemisele. Samas võib selline 
omadus põhjustada plasmamembraani häiritusi, mis võib osutuda rakkudele 
kahjulikuks. Nimelt on raku väliskeskkonnas kaltsiumioonide kontsentratsioon 
kõrge ja tsütosoolis madal ning membraani ebanormaalse läbilaskvuse korral on 
see tasakaal häiritud, mis viib omakorda raku surmani kui kaltsiumi rakusisest 
taset ei saada kontrolli alla. Sellest tulenevalt oli käesoleva töö põhieesmärk 
uurida, kas RPP-de kontsentreerumine ja seondumine rakumembraanile ning 
järgnev sisenemine võib põhjustada kaltsiumi sissevoolu rakkudesse ja akti-
veerida teisi kaltsiumi ioonide vahendatud protsesse.  
Esimeses artiklis sünteesisime potentsiaalseid uusi RPP-sid, mis pärinevad 
inimese kaitsemehhanismis osalevatest valkudest (perforiin, granulüsiin ja 
gransüüm B), et võrrelda nende sisenemisefektiivsust teadaolevate RPP-dega 
12
46 
(penetratiin ja MAP). Uued RPP-d olid küll võimelised rakkudesse sisenema, 
kuid ei olnud nii efektiivsed kui tuntud RPP-d. Samas näitasid fluorestsents-
mikroskoopia tulemused, et uudsed RPP-d paiknesid difuusselt tsütoplasmas, 
mis viitab nende otsesele membraani läbimisele. Sellest tulenevalt uurisime me 
nende RPP-de seondumist raku pinnaga ultrastruktuuri tasemel kasutades 
elektronmikroskoopiat. Saadud tulemused kinnitasid, et RPP-d põhjustavad 
rakumembraani lipiidses kaksikkihis häiritusi ning selle tagajärjel on plasma-
membraani raske detekteerida. Järgmiseks tegime me kindlaks, et RPP-de poolt 
esile kutsutud membraani häiritused on erineva ulatusega, kuna rakusisese kalt-
siumi taseme tõus sõltus kasutatud peptiidist, selle kontsentratsioonist ja raku-
tüübist. Kõige enam mõjutas rakke MAP peptiid, mis põhjustas märkimis-
väärset kaltsiumi kontsentratsiooni tõusu juba esimeste sekunditega väga 
madala peptiidi kontsentratsiooni korral. Lisaks näitasime, et kaltsiumi sisse-
vool aktiveerib ka rakulised mehhanismid nagu lüsosoomide eksotsütoos ja 
membraani parandamise vastus (MPV). MPV tagajärjel mobiliseeritakse kiiresti 
rakusisesed vesiikulid kahjustatud plasmamembraani vahetusse lähedusse ning 
neid vesiikuleid kasutades sulgetakse vigastatud raku membraan, et peatada 
kahjulike ainete sissevool rakkudesse. Seega RPP-de põhjustatud häiritusi saab 
rakkude tasandil elimineerida, mis on väga oluline aspekt RPP-de kui transport-
vektorite välja töötamisel.  
Teises artiklis tahtsime välja selgitada, miks on metsik-tüüpi S413-PV pep-
tiidi (S413-PVwt) ja selle pööratud tuumalokalisatsioonisignaali järjestusega 
analoogi (S413-PVrev) rakkudesse sisenemise efektiivsus palju parem kui S413-
PV segatud järjestusega analoogil (S413-PVscr). Kasutades elektronmik-
roskoopiat näitasime, et S413-PVwt ja S413-PVrev moodustavad raku membraa-
niga seondudes nanopartiklite sarnaseid sfäärilisi struktuure, mis sisenevad 
efektiivselt rakkudesse põhiliselt endotsütoosi teel. S413-PVscr ei olnud võime-
line sellisteks nanopartikliteks assambleeruma ning moodustas raku pinnal 
hoopis suuri ja ebakorrapäraseid agregaate. RPP-de poolt kasutatud endo-
tsütoosirada sarnanes morfoloogiliste näitajate põhjal kaveoliin-sõltuvale endo-
tsütoosile, kuid see oli osaliselt dünamiin-sõltumatu kuna dünamiini inhibeeri-
mine ei blokeerinud täielikult RPP-de sisenemist rakkudesse. Lisaks vesiku-
laarsel teel sisenemisele põhjustasid S413-PVwt ja S413-PVrev rakumembraani 
hägustumist, mistõttu uurisime järgmiseks MPV indutseerimist. Saadud 
tulemused näitasid selget seost nanopartiklite moodustumise ja rakumembraani 
häirituste ulatuse vahel. Nimelt S413-PVwt ja S413-PVrev moodustatud nano-
partiklid aktiveerisid MPV palju madalamal kontsentratsioonil kui ebaregu-
laarsed agregaadid, mida moodustas S413-PVscr. Samas sisenevad S413-PVwt ja 
S413-PVrev efektiivselt rakkudesse juba madalamatel kontsentratsioonidel kui 
on vajalik MPV indutseerimiseks. 
Esimestest töödest tuli välja, et RPP-d on võimelised põhjustama plasma-
membraani häiritusi ning tõstavad rakusisese kaltsiumi taset, kuid see sõltub 
kasutatud peptiidist ja selle kontsentratsioonist. Seetõttu me keskendusime laia-
ulatuslikule RPP-de klassifitseerimisele nende omaduste põhjal. Kolmandas 
47 
artiklis on kaasatud seitse RPP-d erinevatest peptiidiperekondadest – kunstlikud 
peptiidid MAP ja oligoarginiin, kimäärsed peptiidid transportaan ja selle lühem 
analoog TP10 ning valkudest pärinevad peptiidid penetratiin, pVEC ja Tat-
peptiid. Ainsad uuritud RPP-d, mis ei põhjustanud kaltsiumi sissevoolu ja raku-
lisi vastuseid olid oligoarginiin ja Tat-peptiid. Ülejäänutest olid vähem memb-
raani häiritusi põhjustavad penetratiin ja pVEC ning kõige membraani destabili-
seerivateks osutusid TP, TP10 ja MAP. Saadud tulemused on väga heas korre-
latsioonis nende füüsikalis-keemiliste omadustega – primaarsed amfipaatsed 
peptiidid (MAP, TP, TP10) mõjutavad märkimisväärselt plasmamembraani juba 
väga madalatel peptiidi kontsentratsioonidel, sekundaarsed amfipaatsed 
peptiidid (penetratiin ja pVEC) põhjustavad plasmamembraani häiritusi ainult 
kõrgel peptiidi kontsentratsioonil ning mitte-amfipaatsed peptiidid (Tat-peptiid 
ja oligoarginiin) ei mõjuta rakumembraani. Uurides kaltsiumi poolt aktiveeri-
tavaid protsesse tuli välja, et suhteliselt kõrge rakusisese kaltsiumi taseme 
juures aktiveeritakse rakumembraani „mullitamine”, mida olid võimelised esile 
kutsuma ainult primaarselt amfipaatsed RPP-d. Samuti oli MPV aktiveerimine 
väga heas korrelatsioonis rakusisese kaltsiumi taseme tõusuga ning selle mehha-
nismi käivitamine aitab rakkudel üle saada amfipaatsete RPP-de sisenemisega 
kaasnevast stressist.  
Kokkuvõttes näitavad käesoleva töö tulemused, et osade RPP-de sisenemine 
rakkudesse põhjustab plasmamembraani häiritusi või katkemisi. Samas erine-
vate perekondade RPP-d destabiliseerivad rakumembraani erineval määral, 
mistõttu rakusisese kaltsiumi taseme tõus sõltub kasutatud peptiidist ja selle 
kontsentratsioonist. Kaltsiumi ioonide sisenemine aktiveerib omakorda raku-
lised vastused, mis aitavad rakkudel plasmamembraani häiritustega toime tulla 
ning seetõttu on ka tugevalt membraani mõjutavate RPP-de kasutamine 
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